Colorado Governor John Hickenlooper has announced that he wants to find ways to learn more about the medical properties of cannabis. Last month The Nation published a series of articles on the topic. An excerpt:
Cannabis and the unique chemical compounds produced by the plant, called cannabinoids, have been at the center of one of the most exciting—and underreported—developments in modern science. Research on marijuana’s effects led directly to the discovery of a molecular signaling system in the human brain and body, the endocannabinoid system, which plays a crucial role in regulating a broad range of physiological processes: hunger, sleep, inflammation, stress, blood pressure, body temperature, glucose metabolism, bone density, intestinal fortitude, reproductive fertility, circadian rhythms, mood and much more [Martin A. Lee, The Nation].Maybe Gov. Hickenlooper will tap the state's EB-5 funding after submitting a $24.1 billion dollar budget. Colorado is home to Cannabis Science.
I think I saw Gov. Hickenlooper at Ojo Caliente yesterday.
Stock in Cannabis Science gained 25% today on a volume of over 17 million shares: it is just one company posed to make even further profits on the cultivation and sales of legal cannabis. Michigan-based Creative Edge Nutrition is ready to distribute in Canada through its subsidiary, CEN Biotech. CEN markets 24 strains to outlets in Uruguay, The Netherlands, Israel, Mexico, Colombia, Iran, and North Korea. CBIS is just one publicly traded US company: Endocan Corp., GW Pharmaceuticals, GrowLife, and Medical Marijuana, Inc. also trade.
Disclosure: I am long CBIS and PHOT, which gained over 7% today.